AFP and hepatocellular carcinoma: Second, our prognostic benchmarking did not include contemporary multi‐parameter serologic scores such as GALAD or ASAP, which integrate demographic variables and multiple tumour markers and have been reported to outperform AFP alone for HCC detection and risk stratification.